chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Client became dizzy and complained of ringing in her ears. Became pale and diaphoretic. Admitted she has anxiety and felt she was having anxiety attack. She also admitted she does this same thing with any and every injection she has gotten. Helped her lie on floor. Vital signs stable. Remained A and O X 4 entire time. Only took about 5-7 minutes and she began to feel better. Color returned to normal. Once back up in chair she was given graham crackers and water. Observed and additional 15 minutes once she felt better. Educated client to always make healthcare providers aware of this effect before any future injections.
Mild rash on the small of his back at the bottom down to each of his butt cheeks and down both his legs slightly/Rash in the hip area; This is a spontaneous report from a contactable consumer (patient). A 61-year-old male patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; solution for injection; lot number was not reported), via an unspecified route of administration, administered in the left arm on 08Mar2021 15:00 (at the age of 61-years-old) as dose 1, single for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. The patient reported that he received the first Pfizer COVID vaccine on 08Mar2021 at 15:00. On 09Mar2021, when he came home from work the patient noticed that he had a mild rash on the small of his back at the bottom down to each of his butt cheeks and down both his legs slightly. He had a little of the rash in the hip area and no other reactions or issues. The patient stated that he just had a minor rash in those areas. The patient first noticed rash in the afternoon around 15:00. The patient wanted to know if this was a normal or a common thing and if it is okay to take a Benadryl or something like it in association with the slight rash. The patient denied receiving any other vaccines the same day or 4 weeks prior. He has no history of problems with vaccines in past. The outcome of the event was not recovered.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Having pain in the lower back; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of BACK PAIN (Having pain in the lower back) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced BACK PAIN (Having pain in the lower back). At the time of the report, BACK PAIN (Having pain in the lower back) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant products were reported.  No treatment information provided.
MOC states injection site of left arm was itchy, "angry" inflamed this past weekend.  States today the site looks like a bug bite and is no longer bothering child.
Covid Vaccine Documentation: PT admitted 10/2/21 positive for covid. PT received Janssen vaccine Lot # 1802068 on 3/5/21. PT is 74 yom with history of leukemia and Covid complaining of SOB, on oxygen at home. PT stated they were diagnosed with Covid 922/21. presented to ED 10/2/21. POC SARS COV2 ANTIGEN POS 10/2/21
Information has been received from a registered nurse (R.N.) concerning a female patient, under 6 years of age, who was vaccinated with Varivax at 12 months of age. Subsequently, the patient's mother reported that her child developed chickenpox despite vaccination. It is unknown how long after the vaccination the child developed chickenpox and the office does not have any documentation to support this claim, nor any details. It was noted that medical attention was sought and that the patient recovered. No product quality complaint was involved. Additional information is not expected.
severe nausea; headache; dizziness; cant sleep; This is a spontaneous report from a contactable consumer (Parent). A 13-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Lot number: Unknown), via an unspecified route of administration on 23Jun2021 at 10:00 (at the age of 13-year-old), as dose 2, single in right arm, for COVID-19 immunization at Urgent Care Center. The patient's medical history and concomitant medications were not reported. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine or any other medications within 2 weeks of vaccination. The patient previously received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Lot number: unknown), via an unspecified route of administration, on an unspecified date, as single dose for COVID-19 immunization. On 23Jun2021, several hours after the vaccine, the patient experienced severe nausea, a headache and dizziness. Patient also reported that she couldn't sleep, even after taking Advil pm. Reporter, stated they did not sought treatment but may if that continues or worsens. Adverse events resulted in doctor or other healthcare professional office/clinic visit. The patient had no COVID prior vaccination and was not tested COVID post vaccination. The clinical outcome of all the events was not resolved.  Information on the lot/batch number has been requested.
This spontaneous report as received from a licensed practical nurse refers to a patient of unknown age. In MAY-2016 the patient was vaccinated with GARDASIL (dose, route of administration, lot # and expiration date were not reported) for prophylaxis. Other suspect therapies included GARDASIL 9 (dose, route of administration, lot # and expiration date were not reported). On 22-AUG-2017 the patient experienced interchange of vaccine products and off label use. On an unknown date the patient experienced inappropriate schedule of drug administration and no adverse event.
PARENT REPORTED INFANT DEATH. PATIENT WAS FOUND IN CRIB, FACE DOWN DECEASED ON 01/13/2020 IN THE AFTERNOON.
Moderna booster caused hives for my 20 year old son after 2 weeks of booster vaccine.
Red area on left arm that is warm to the touch. Patient reports arm was sore 10/15/14 but patient did not notice the red area until later in the evening 10/15. She noticed that it was warm to the touch today. The area is not raised and the soreness has disipated since yesterday but the redness remains.
Usual sore arm; She is a "walker" but could only walk ½ mile; her heart would "pump"; palpitations; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Usual sore arm), GAIT DISTURBANCE (She is a "walker" but could only walk ½ mile), HEART RATE INCREASED (her heart would "pump") and PALPITATIONS (palpitations) in a 79-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 026L20A) for COVID-19 vaccination.     The patient's past medical history included Low blood pressure and GERD. Concurrent medical conditions included Sulfonamide allergy and Food allergy (Allergic to crab meat).    On 26-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 26-Jan-2021, the patient experienced PAIN IN EXTREMITY (Usual sore arm), GAIT DISTURBANCE (She is a "walker" but could only walk ½ mile), HEART RATE INCREASED (her heart would "pump") and PALPITATIONS (palpitations). At the time of the report, PAIN IN EXTREMITY (Usual sore arm), GAIT DISTURBANCE (She is a "walker" but could only walk ½ mile), HEART RATE INCREASED (her heart would "pump") and PALPITATIONS (palpitations) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant product use was not provided by the reporter.  Treatment information was not provided.   This case was linked to MOD-2021-049370 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 07-May-2021: AE contact information updated
2 days after vaccination, I developed a rash on my neck, it then spread to my face on Tuesday afternoon, and to my arms and leg. The rash wasn't very red or swollen, except for on my neck. It itched intermittently, was warm to the touch. I had an IUD placed 2 hrs before the vaccination, and fillings at the dentist (requiring anesthesia) the morning after. My PCP recommended I take zyrtec 3 times a day for 3-5 days, beginning 3/24/2021. The neck was the last to improve. All was normal by Sunday, 3/28/2021.
Information has been received from a lawyer regarding a case in litigation concerning a female patient (age unknown). The patient's medical history, concurrent conditions and concomitant medication use were not provided. On or about 2015, the patient was vaccinated with ZOSTAVAX, (lot# and route unknown) as recommended for routine adult health maintenance and for the prevention of shingles.  The vaccine did not prevent shingles as intended, but rather caused the patient to contract a persistent strain of herpes zoster. On or about 29-MAY-2013 (conflicting information; the onset date of the patient's symptoms is prior to the vaccination date), the patient was treated at a hospital for a blistering vesicular outbreak which was diagnosed as shingles. The patient was prescribed prednisone for management of her painful symptoms and chronic pain.  As a direct and proximate result of the ZOSTAVAX vaccine, and/or despite receiving ZOSTAVAX for long-term prevention of shingles, the patient suffered painful injuries and damages, and required extensive medical care and treatment. As a further proximate result, the patient has suffered and will continue to suffer significant medical expenses, and pain and suffering, and other damages.   Additional information has been requested.
Within 3 hrs of PNEUMOVAX immunization given 10/10/13 pt had pain develop in her arm where shot was given and it was hard to move. Applied heat. No fever but before bed felt chilled. Next day she noted arm had swelled moderately and redness noted circumferentially around her arm in a band approx 4 cm around, warm to touch and indurated/tender. No other rashes.
This spontaneous report was received from a healthcare worker and refers to 6 months old patient of unknown gender. The patient's concurrent conditions, past medical history were not reported. On 15-DEC-2015, the patient was vaccinated with an improperly stored ROTATEQ (lot # K014826, expiry date 28-MAY-2016, dose, strength, vaccination site, dose number unspecified). Concomitant medications were not provided. No adverse effects were reported. Product quality complaint (PQC) was not reported. On 26-JAN-2016, a phone call was placed to the physician. The physician was unavailable at the time of call. The phone call was transferred to the Certified Medical Assistant (CMA). The C.M.A was unable to place specific lot numbers for each of the reported vaccines that experienced a temperature excursion; M-M-R II, ROTATEQ and VAQTA, with the immunization already supplied for patient identifiers, date of birth and date of vaccination, at this time. The C.M.A will need to review the records. This is one of the several reports received from the same reporter. Additional information has been requested.
small lump on her left arm where she received the vaccine; This is a spontaneous report from a contactable consumer (patient). This 41-year-old female patient received bnt162b2 (BNT162B2, Pfizer-BioNTech Covid-19 mRNA Vaccine, Solution for injection, Batch/Lot number was not reported), via an unspecified route of administration on an unspecified date as DOSE NUMBER UNKNOWN, SINGLE for covid-19 immunisation. The patient medical history and concomitant medications were not reported. On an unspecified date patient experienced small lump on her left arm where she received the vaccine, and it is not a lymph node. The outcome of event was unknown.   Information about the Lot/batch number has been requested.  Follow-up attempts are completed. No further information is expected.
Patient received 2nd dose of Moderna. 15 minutes after the shot patient said she was feeling dizzy. We gave her some water and took her blood pressure. She sat and we observed her. As time progressed, she started to get itchy, her hands and then the soles of her feet. We gave her 50mg of Benadryl and kept watching the patient. She did not have any shortness of breath or anaphylaxis. We kept observing the patient, and she continued to improve. We informed her to keep taking Benadryl 50mg every 4-6 hours and to call 911 if anything gets worse.
Fever, chills, body aches, flu-like symptoms, no upper respiratory problems, sore arm.
SIRVA in left shoulder after 3rd dose of Pfizer vaccine.  Pain increased the second week and became constant afterwards.  Also experienced Shingles outbreak in same shoulder along C6 dermatome 2 weeks after 3rd dose of Pfizer vaccine.  Prescribed Acyclovir 800 MG 5 times a day for 7 days.  SIRVA treatment calls for MRI, PT, Orthopedist appointments.
On 4/28 I went to my PCP with extreme pain from my neck to hand in right arm. I had pain before that but was hoping to be able to wait till an upcoming apt.  I was sent for xrays of my neck & shoulder, which shows some degenerative disks.  I was then sent to see a spin Dr. and did 13 weeks of physical therapy so I could have an MRI done.  The MRI didn't look like it was causing the problem so I was then sent for a nerve test, which also showed OK. I also have dizzyness & lightheadness.    I had  issues before  4/28 apt. but not so servere so not sure exactly when they started.  I had gone into VAERS to see if I could find any other people with similiar problems and did so I am now filling out this form.
Adverse effects; A spontaneous report was received from a consumer of an unknown age and gender who received Moderna's COVID-19 vaccine (mRNA-1273) and experienced some adverse effects.  The patient's medical history was not provided. No relevant concomitant medications were reported.   On 06 Jan 2021, prior to the onset of the events, the patient received their first of two planned doses of mRNA-1273 (lot/batch number: unknown) prophylaxis of COVID-19 infection.   On Unknown date, the patient experienced some adverse effects. Treatment for the event was not provided.  Action taken with mRNA-1273 in response to the event was not reported.   The outcome for the event some adverse effects was not reported.; Reporter's Comments: Based on the current available information and temporal association between the use of the product and the start date of the event, a causal relationship cannot be excluded.
Initially dry cough, feverish, progressing to sore throat. Received rapid covid test and tested negative on 07/12. Saw provider on 07/12 and was prescribed Tessalon Perles. Didn?t ease the cough, progressed into stuffy nose and then running nose during 07/13-15. Symptoms gone by 07/18.
Information has been received from a RN concerning a 13 month old female pt in daycare who on 03/15/02 was vaccinated SC in the right thigh with a first dose of varicella virus vaccine live (Lot # 639132/0502L).  The nurse stated that the pt may have been vaccinated with improperly stored varicella virus vaccine live.  On 03/15/02, the pt was concomitantly vaccinated SC in the left thigh with a first dose of MMRII (Lot # 641019/1215L)and a first dose of Prevnar IM in the left thigh (Lot # 484-132). Unspecified medical attention was sought. On 01/13/04, the pt developed a pus filled rash on his trunk. A product quality complaint was not involved. The reporter also mentioned other pt's who may have been vaccinated with improperly stored varicella virus vaccine live (WAES # 0403USA02035, 0403USA02038, 0403USA02039 & 0403USA02036).  These pt's included other children in the same daycare who also reported having chickenpox within the same time period (WAES # 0403USA02038 & 0403USA02039).  Another child in the same daycare also reported having chickenpox within the same time period, but had not previously received varicella virus vaccine live. Additional information has been requested.
Information has been received from a physician concerning a 13 year old white female patient who on 12/04/1996 was vaccinated in the LA with a first dose of varicella virus vaccine live. The RN reproted the adverse event onset date on 02/20/2005. The physician reported that the patient on 20-FEB-2005 developed a mild case of varicella.the patient was reported as recovering. No addditonal information is expected.
Very sick; Swelling; Redness; Muscle Aches; Joint Aches; Fatigue; temperature; Throwing up; This spontaneous case was reported by a consumer and describes the occurrence of ILLNESS (Very sick), SWELLING (Swelling), ERYTHEMA (Redness), MYALGIA (Muscle Aches) and ARTHRALGIA (Joint Aches) in a 59-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 043B21A and 040B21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concomitant products included LISINOPRIL and LEVOTHYROXINE for an unknown indication.   On 22-May-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 19-Jun-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient experienced ILLNESS (Very sick), SWELLING (Swelling), ERYTHEMA (Redness), MYALGIA (Muscle Aches), ARTHRALGIA (Joint Aches), FATIGUE (Fatigue), PYREXIA (temperature) and VOMITING (Throwing up). The patient was treated with IBUPROFEN at a dose of 1 dosage form. At the time of the report, ILLNESS (Very sick), SWELLING (Swelling), ERYTHEMA (Redness), MYALGIA (Muscle Aches), ARTHRALGIA (Joint Aches), FATIGUE (Fatigue), PYREXIA (temperature) and VOMITING (Throwing up) outcome was unknown.        mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosing remained unchanged.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   This case was linked to MOD-2021-231095 (Patient Link).
About two minutes after vaccination, patient became pale and asked for water. He then collapsed to the floor. We got him water and asked if he had eaten anything that day. He stated "no." We got him some chips. He said he was ok and feeling better with chips and water. Meanwhile, paramedics were on the way. Paramedics took his vital signs. He was feeling better and did not leave with paramedics, but rather went home.
patient reports a bump on arm where injection was given. redness around the area, some pain and warmth on injection site.
ARM FELT SORE, SKIN TURNED A DIFFERENT COLOR AT INJECTION SITE, AT TIMES HAS A COLD FEELING IN ARM.
the patient began experiencing a facial tic and abnormal eye blinking; the patient began experiencing a facial tic and abnormal eye blinking; This spontaneous report has been received from a health care worker, concerning to a 25-years-old female patient who was also the reporter's daughter.  The patient's concurrent conditions, medical history, past drug reactions or allergies and concomitant medications were not reported.  On an unspecified date, the patient was vaccinated with HPV rL1 6 11 16 18 31 33 45 52 58 VLP vaccine (yeast) (GARDASIL 9) (strength, dose, route of administration, anatomical location, lot# and expiration date were not reported) or Quadrivalent Human Papillomavirus (Types 6,11,16,18) Recomb. Vaccine (GARDASIL) strength, dose, route of administration, anatomical location, lot# and expiration date were not reported) for prophylaxis.  On an unspecified date (reported as after the vaccine administration), the patient experienced facial tic (facial spasm) and abnormal eye blinking (corneal reflex decreased). At the reporting time, the patient had not recovered from the events of facial spasm and corneal reflex decreased.  The causal relationship between the events of facial spasm and corneal reflex decreased and HPV rL1 6 11 16 18 31 33 45 52 58 VLP vaccine (yeast) (GARDASIL 9) or Quadrivalent Human Papillomavirus (Types 6,11,16,18) Recomb. Vaccine (GARDASIL) was unknown.
Pain, swelling approximately 3 inches in diameter, redness, hot to touch,  within 12 hours. Increasing pain for another 48 hours and chills and fever of 100.2 . Nausea at 60 hours after that lasted for 8 hours. Localized itching and rash  lasted about 48 hours and started on day 4 after vaccination.  Pain and other symptoms are minimal on day 6 after.
This is a spontaneous report from a contactable pharmacist received via a Pfizer sales representative.  A patient of unspecified age, ethnicity and gender received PREVNAR 13; (batch/lot number unknown), via an unspecified route of administration on an unspecified as single dose for immunization.  The patient medical history and concomitant medications were not reported.  The patient experienced limitation of arm movement on an unspecified date. The outcome of limitation of arm movement was unknown. The reporting pharmacist does believe that the limitation of arm movement was due to pneumococcal 13-valent conjugate vaccine (diphtheria crm197 protein).
Patient unintentionally  received a dose of Moderna Covid vaccine 35 days after, it is believed, completing the Pfizer series in August 2021 (#1- 8/5 or 8/6  #2- 8/26/21)  at another facility.   Per current medical consultant - patient did not experience any adverse effects associated with the Moderna vaccination.
Covid vaccine monitoring documentation: PT admission 1/22/22 ? 1/27/22. PT received COVID-19, mRNA, LNP-S, PF, 30 mcg/0.3 mL dose (PFIZER) 01/30/2021 EL8982. COVID-19, mRNA, LNP-S, PF, 30 mcg/0.3 mL dose (PFIZER) 02/20/2021 EL3247. COVID-19, mRNA, LNP-S, PF, 30 mcg/0.3 mL dose (PFIZER) 12/03/2021 FF2590.
Pt was transferred for general surgery eval due to a periumbilical hernia containing depressed loops of bowel.  It was believed he had a bowel obstruction.  Pt tested prior to OR.
This spontaneous report was received from a pharmacist refers to a 59 year old patient of unknown gender. No medical history or concurrent conditions reported. On 27-SEP-2014, the patient was vaccinated with PNEUMOVAX 23 (dose, strength, route of administration and lot number not provided). No co-suspect or concomitant therapies were reported. The dose that the patient received had expired on 20-JUL-2014. Additional information has been requested.
Headache, Myalgia, injection site discomfort, fatigue, and tiredness Narrative:
Patient developed zoster rash of left arm; admitted to hospital. Meningitis (viral).